|
|
Prepublished online as a Blood First Edition Paper on May 31, 2002; DOI 10.1182/blood-2002-01-0124.

Submitted January 16, 2002
Accepted March 15, 2002
Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality
Norio Suzuki, Osamu Ohneda, Satoru Takahashi, Masato Higuchi, Harumi Y Mukai, Tatsutoshi Nakahata, Shigehiko Imagawa, and Masayuki Yamamoto*
Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Tsukuba, Ibaraki, Japan
Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan
Product Research Laboratory, Chugai Pharmaceutical Co Ltd, Tokyo, Japan
Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan
Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Tsukuba, Ibaraki, Japan; Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan
* Corresponding author; email: masi{at}tara.tsukuba.ac.jp.
Erythropoietin (Epo) and its receptor (EpoR) are indispensable to erythropoiesis. While additional roles such as neuroprotection and heart development have been reported for the Epo-EpoR system besides angiogenesis, the precise contribution of Epo-EpoR to these nonhematopoietic tissues requires clarification. Exploiting a GATA-1 minigene cassette with hematopoietic regulatory domains, we established two lines of transgene-rescued EpoR-null mutant mice expressing EpoR exclusively in the hematopoietic lineage. Surprisingly, despite the lack of EpoR expression in nonhematopoietic tissues, these mice develop normally and are fertile. As such, we could exploit them for analyzing the roles of the Epo-EpoR system in adult hematopoiesis and in nonhematopoietic tissues. These rescued lines showed a differential level of EpoR expression in erythroid cells; one expressed approximately 40%, while the other expressed 120% of the wild type EpoR level. A colony formation assay showed that erythroid progenitors in the two mutant lines exhibit distinct sensitivity to Epo. The circulating Epo level was much higher in the transgenic line with a lower EpoR expression. In response to induced anemia, the plasma Epo concentrations increased in both lines. Notably, the timing of the peak of plasma Epo concentration was delayed in both lines of rescued mice in comparison with wild type, suggesting that, in wild type mice, nonhematopoietic EpoR contributes to the regulation of plasma Epo concentration. We, thus, conclude that nonhematopoietic expression of EpoR is dispensable to normal mouse development and that the expression level of EpoR regulates erythropoiesis by controlling the sensitivity of erythroid progenitors to Epo.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Sulahian, O. Cleaver, and L. J.-s. Huang
Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia
Blood,
May 21, 2009;
113(21):
5287 - 5297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Ream, R. Chandra, M. Peavey, A. M. Ray, S. Roffler-Tarlov, H.-G. Kim, W. C. Wetsel, H. A. Rockman, and D. M. Chikaraishi
High oxygen prevents fetal lethality due to lack of catecholamines
Am J Physiol Regulatory Integrative Comp Physiol,
September 1, 2008;
295(3):
R942 - R953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sathyanarayana, A. Dev, J. Fang, E. Houde, O. Bogacheva, O. Bogachev, M. Menon, S. Browne, A. Pradeep, C. Emerson, et al.
EPO receptor circuits for primary erythroblast survival
Blood,
June 1, 2008;
111(11):
5390 - 5399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Obara, N. Suzuki, K. Kim, T. Nagasawa, S. Imagawa, and M. Yamamoto
Repression via the GATA box is essential for tissue-specific erythropoietin gene expression
Blood,
May 15, 2008;
111(10):
5223 - 5232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Paffett-Lugassy, N. Hsia, P. G. Fraenkel, B. Paw, I. Leshinsky, B. Barut, N. Bahary, J. Caro, R. Handin, and L. I. Zon
Functional conservation of erythropoietin signaling in zebrafish
Blood,
October 1, 2007;
110(7):
2718 - 2726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-Y. Chen, P. Asavaritikrai, J. T. Prchal, and C. T. Noguchi
Endogenous Erythropoietin Signaling Is Required for Normal Neural Progenitor Cell Proliferation
J. Biol. Chem.,
August 31, 2007;
282(35):
25875 - 25883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Asaumi, Y. Kagaya, M. Takeda, N. Yamaguchi, H. Tada, K. Ito, J. Ohta, T. Shiroto, K. Shirato, N. Minegishi, et al.
Protective Role of Endogenous Erythropoietin System in Nonhematopoietic Cells Against Pressure Overload-Induced Left Ventricular Dysfunction in Mice
Circulation,
April 17, 2007;
115(15):
2022 - 2032.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Madeddu and C. Emanueli
Switching on Reparative Angiogenesis: Essential Role of the Vascular Erythropoietin Receptor
Circ. Res.,
March 16, 2007;
100(5):
599 - 601.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nakano, K. Satoh, Y. Fukumoto, Y. Ito, Y. Kagaya, N. Ishii, K. Sugamura, and H. Shimokawa
Important Role of Erythropoietin Receptor to Promote VEGF Expression and Angiogenesis in Peripheral Ischemia in Mice
Circ. Res.,
March 16, 2007;
100(5):
662 - 669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Yoon, B. Kim, M. Kwon, and J. T. Prchal
Hematopoietic Specific GATA-1-Improved Cre Mouse for Erythroid-Specific Gene Modification.
Blood (ASH Annual Meeting Abstracts),
November 16, 2006;
108(11):
1291 - 1291.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Y. Mukai, H. Motohashi, O. Ohneda, N. Suzuki, M. Nagano, and M. Yamamoto
Transgene Insertion in Proximity to thec-myb Gene Disrupts Erythroid-Megakaryocytic Lineage Bifurcation
Mol. Cell. Biol.,
November 1, 2006;
26(21):
7953 - 7965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Davidson and D. M. Yellon
Dissecting out the mechanism of cardioprotection by endogenous erthyropoietin using genetic engineering
Cardiovasc Res,
August 1, 2006;
71(3):
408 - 410.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tada, Y. Kagaya, M. Takeda, J. Ohta, Y. Asaumi, K. Satoh, K. Ito, A. Karibe, K. Shirato, N. Minegishi, et al.
Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion
Cardiovasc Res,
August 1, 2006;
71(3):
466 - 477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Nakajima, S. Okano, H. Harada, T. Kusaka, X. Gao, T. Hosoya, N. Suzuki, S. Takahashi, and M. Yamamoto
Transgenic rescue of erythroid 5-aminolevulinate synthase-deficient mice results in the formation of ring sideroblasts and siderocytes
Genes Cells,
June 1, 2006;
11(6):
685 - 700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. Suh, J. Gooya, K. Renn, A. D. Friedman, P. F. Johnson, and J. R. Keller
C/EBP{alpha} determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation
Blood,
June 1, 2006;
107(11):
4308 - 4316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Menon, J. Fang, and D. M. Wojchowski
Core erythropoietin receptor signals for late erythroblast development
Blood,
April 1, 2006;
107(7):
2662 - 2672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Satoh, Y. Kagaya, M. Nakano, Y. Ito, J. Ohta, H. Tada, A. Karibe, N. Minegishi, N. Suzuki, M. Yamamoto, et al.
Important Role of Endogenous Erythropoietin System in Recruitment of Endothelial Progenitor Cells in Hypoxia-Induced Pulmonary Hypertension in Mice
Circulation,
March 21, 2006;
113(11):
1442 - 1450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Um and H. F. Lodish
Antiapoptotic Effects of Erythropoietin in Differentiated Neuroblastoma SH-SY5Y Cells Require Activation of Both the STAT5 and AKT Signaling Pathways
J. Biol. Chem.,
March 3, 2006;
281(9):
5648 - 5656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Li, G. Takemura, Y. Li, S. Miyata, M. Esaki, H. Okada, H. Kanamori, N. C. Khai, R. Maruyama, A. Ogino, et al.
Preventive Effect of Erythropoietin on Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy
Circulation,
January 31, 2006;
113(4):
535 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Hardee, M. O. Arcasoy, K. L. Blackwell, J. P. Kirkpatrick, and M. W. Dewhirst
Erythropoietin Biology in Cancer
Clin. Cancer Res.,
January 15, 2006;
12(2):
332 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Suzuki, S. Imagawa, C. T. Noguchi, M. Yamamoto, and U. Klingmuller
Do {beta}-globin, GATA-1,or EpoR regulatory domains specifically mark erythroid progenitors in transgenic reporter mice?
Blood,
November 1, 2004;
104(9):
2988 - 2989.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Xue, X. Chen, Y. Chang, and J. J. Bieker
Regulatory elements of the EKLF gene that direct erythroid cell-specific expression during mammalian development
Blood,
June 1, 2004;
103(11):
4078 - 4083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Weiss
New Insights Into Erythropoietin and Epoetin Alfa: Mechanisms of Action, Target Tissues, and Clinical Applications
Oncologist,
December 1, 2003;
8(90003):
18 - 29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Suzuki, N. Suwabe, O. Ohneda, N. Obara, S. Imagawa, X. Pan, H. Motohashi, and M. Yamamoto
Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels
Blood,
November 15, 2003;
102(10):
3575 - 3583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J Smith, A. J Bleyer, W. C Little, and D. C Sane
The cardiovascular effects of erythropoietin
Cardiovasc Res,
September 1, 2003;
59(3):
538 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Heeschen, A. Aicher, R. Lehmann, S. Fichtlscherer, M. Vasa, C. Urbich, C. Mildner-Rihm, H. Martin, A. M. Zeiher, and S. Dimmeler
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
Blood,
August 15, 2003;
102(4):
1340 - 1346.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|